During the past decade, Marmara University Medical Faculty conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marmara University Medical Faculty" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Actelion" with 4 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "Ark Biosciences Inc." with 1 trials sponsored and "Celgene" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marmara University Medical Faculty" #1 collaborator was "Ark Biosciences Pty Ltd." with 1 trials as a collaborator, "European Society of Anaesthesiology and Intensive Care" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "Istanbul University" with 1 trials as a collaborator and "KfH Foundation for Preventive Medicine" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Marmara University Medical Faculty" are "Arthritis, Psoriatic" (3 trials), "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Prostate Cancer" (2 trials), "Cardiovascular Disease" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Marmara University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Marmara University Medical Faculty" are "Drug" (16 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Guselkumab" (4 trials), "Degarelix" (2 trials), "Macitentan 10 mg" (2 trials) and "AK0529" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marmara University Medical Faculty" are 17 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Marmara University Medical Faculty". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Marmara University Medical Faculty, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Marmara University Medical Faculty, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".